Genprex Inc
Change company Symbol lookup
Select an option...
GNPX Genprex Inc
BAC Bank of America Corp
SXRRU POET Biorefining Hudson LLC
PBCT People's United Financial Inc
LPI Laredo Petroleum Inc
LOW Lowe's Companies Inc
LNG Cheniere Energy Inc
LNC Lincoln National Corp
LITE Lumentum Holdings Inc
LH Laboratory Corporation of America Holdings
Go

Health Care : Biotechnology |
Company profile

Genprex, Inc. is a clinical-stage gene therapy company. The Company is focused on developing cancer-based upon its novel technology platform, including its initial product candidate, Oncoprex, immunogene therapy, or Oncoprex. Oncoprex consists of a tumor suppressor gene inserted into a patient’s cells that has immunomodulatory effects and is thereby considered an immunogene therapy. The gene is one of a series of genes whose therapeutic use is covered by a license from The University of Texas MD Anderson Cancer Center (MD Anderson). It is also developing a pre-clinical gene therapy that is covered by a license from the University of Pittsburgh of the Commonwealth System of Higher Education that has the potential to cure type 1 and type 2 diabetes. It is developing its product candidate to be administered with targeted therapies and with immunotherapies for non-small cell lung cancer (NSCLC).

Closing Price
$3.12
Day's Change
-0.12 (-3.70%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.46
Day's Low
3.04
Volume
(Heavy Day)
Volume:
5,066,732

10-day average volume:
1,885,101
5,066,732

Unable to locate that news article. Back to news results

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.